Co-Authors
This is a "connection" page, showing publications co-authored by Alessandro Bartoloni and Danilo Malandrino.
Connection Strength
0.171
-
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome. Eur J Endocrinol. 2021 May 28; 185(1):137-144.
Score: 0.059
-
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
Score: 0.056
-
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
Score: 0.055